Jun 8, 2023 3:00 PM EDT 2023 Jefferies Global Healthcare Conference New York, NY Webcast Audio Read more
Dec 7, 2022 5:00 PM EDT Top-line Results from Phase 3 RELIANCE I Trial for REL-1017 as an Adjunctive Treatment for Major Depressive Disorder Conference Call Read more
Feb 23, 2022 8:30 AM EDT Relmada Results of Human Abuse Potential Study of REL-1017 vs. Ketamine Read more
Jul 27, 2021 8:30 AM EDT Top-Line Results of Study Evaluating REL-1017 vs Oxycodone for Abuse Potential
Apr 27 – Apr 30, 2021 American Society for Pharmacology and Experimental Therapeutics Annual Meeting at Experimental Biology 2021
Oct 15, 2019 8:30 AM EDT Conference Call to Discuss Results of Phase 2 Study of REL-1017 for Treatment Resistant Depression
